Remote Director, Clinical Supply Chain & Strategy

BBOT; United States; Remote; USD 200,000 - 250,000; Full time

Job summary

BridgeBio Oncology Therapeutics is seeking a Director of Clinical Supply Chain to shape the strategy for global clinical supply across oncology programs, turning pipeline priorities into actionable plans and ensuring on-time delivery for trials in a fast-growing environment.

This hands-on leadership role requires building supply models, managing inventory and budgets, coordinating with clin ops, regulatory and manufacturing, and elevating risk management to leadership with clear mitigations.

Qualifications

• Bachelor’s degree in related field required.
• 10+ years in clinical supply chain with 5+ in lead role.
• In‑depth knowledge of clinical trial operations, cGMP/GDP regulations, and global clinical supply chain best practices.

Responsibilities

• Define long-range clinical supply strategy across BBOT's oncology programs.
• Line up sourcing, production, and distribution with pipeline direction and lead the calls for leadership.
• Work with clin ops, regulatory, and manufacturing to keep trial needs and supply timelines in sync.
• Spot supply risks early and prepare mitigation plans before they hit trial timelines.
• Source commercial comparators: due diligence, vendor coordination, and regulatory compliance country to country.

Skills

Excel modeling

Supply chain leadership

Forecasting

Budget management

Vendor management

Cross-functional collaboration

Education

Bachelor’s degree in Supply Chain Management, Life Sciences, or related field

Job description

BridgeBio Oncology Therapeutics is seeking a Director of Clinical Supply Chain to shape the strategy for global clinical supply across oncology programs, turning pipeline priorities into actionable plans and ensuring on-time delivery for trials in a fast-growing environment.

This hands-on leadership role requires building supply models, managing inventory and budgets, coordinating with clin ops, regulatory and manufacturing, and elevating risk management to leadership with clear mitigations.